Common Stock, Shares, Outstanding of Kura Oncology, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Kura Oncology, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Kura Oncology, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 87,016,000, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Kura Oncology, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 87,016,000 +9,267,000 +12% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 86,797,000 +10,375,000 +14% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 80,778,000 +4,597,000 +6% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 78,229,000 +3,879,000 +5.2% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 77,749,000 +3,498,000 +4.7% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 76,422,000 +2,279,000 +3.1% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 76,181,000 +7,742,000 +11% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 74,350,000 +6,036,000 +8.8% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 74,251,000 +7,357,000 +11% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 74,143,000 +7,305,000 +11% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 68,439,000 +1,803,000 +2.7% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 68,314,000 +1,742,000 +2.6% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 66,894,000 +390,000 +0.59% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 66,838,000 +542,000 +0.82% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 66,636,000 +373,000 +0.56% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 66,572,000 +378,000 +0.57% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 66,504,000 +9,877,000 +17% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 66,296,000 +10,082,000 +18% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 66,263,000 +20,833,000 +46% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 66,194,000 +20,810,000 +46% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 56,627,000 +11,330,000 +25% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 56,214,000 +11,025,000 +24% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 45,430,000 +7,261,000 +19% 31 Mar 2020 10-Q 04 May 2020 2020 Q1
Q4 2019 45,384,000 +7,236,000 +19% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 45,297,000 +7,283,000 +19% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 45,189,000 +12,016,000 +36% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 38,169,000 +5,313,000 +16% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 38,148,000 +8,724,000 +30% 31 Dec 2018 10-K 25 Feb 2020 2019 FY
Q3 2018 38,014,000 +8,887,000 +31% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 33,173,000 +13,185,000 +66% 30 Jun 2018 10-Q 06 Aug 2018 2018 Q2
Q1 2018 32,856,000 +13,188,000 +67% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 29,424,000 +10,076,000 +52% 31 Dec 2017 10-K 05 Mar 2019 2018 FY
Q3 2017 29,127,000 +10,082,000 +53% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 19,988,000 +1,245,000 +6.6% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 19,668,000 +1,227,000 +6.7% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 19,348,000 +1,210,000 +6.7% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 19,045,000 +8,109,000 +74% 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 18,743,000 +8,134,000 +77% 30 Jun 2016 10-Q 10 Aug 2016 2016 Q2
Q1 2016 18,441,000 +8,124,000 +79% 31 Mar 2016 10-Q 11 May 2016 2016 Q1
Q4 2015 18,138,000 +17,727,000 +4313% 31 Dec 2015 10-K 14 Mar 2017 2016 FY
Q3 2015 10,936,000 +5,936,000 +119% 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 10,609,000 +5,609,000 +112% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 10,317,000 +5,317,000 +106% 31 Mar 2015 10-Q 13 May 2015 2015 Q1
Q4 2014 411,000 -4,589,000 -92% 31 Dec 2014 10-K 17 Mar 2016 2015 FY
Q3 2014 5,000,000 0 0% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 5,000,000 0 0% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 5,000,000 0 0% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 5,000,000 0 0% 31 Dec 2013 10-K 27 Feb 2015 2014 FY
Q3 2013 5,000,000 0 0% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 5,000,000 0 0% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 5,000,000 0 0% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 5,000,000 0 0% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 5,000,000 0 0% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 5,000,000 0 0% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 5,000,000 0 0% 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 5,000,000 0 0% 31 Dec 2011 10-K 28 Mar 2013 2012 FY
Q3 2011 5,000,000 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 5,000,000 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q1 2011 5,000,000 31 Mar 2011 10-Q 15 May 2012 2012 Q1
Q4 2010 5,000,000 31 Dec 2010 10-K 30 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.